Homeopathic products should not be sold in Australian pharmacies because they place consumers at “unacceptable risk,” an independent review of pharmacy regulation for the Australian Department of Health has found.
In his interim report, review panel chairman Stephen King found homeopathy and homeopathic products should be kept out of pharmaceutical benefits scheme-approved pharmacies.
“The only defense put to the panel regarding homeopathy was that it was harmless and able to be used as a placebo in certain circumstances,” the report said. “The panel does not believe that this argument is sufficient to justify the continued sale of these products in pharmacies.”
Ian Carr, a pharmacist and member of Friends of Science in Medicine, welcomed the finding and said homeopathic products could be harmful if used in lieu of evidence-based treatments for serious conditions.
“My biggest complaint about the status of homeopathy is not that people are essentially putting placebos into their bodies, it’s that they are putting their trust in a certain way of thinking that has no evidence base,” he said.
“It means they’re not looking in the right places for information, which is concerning if they are suffering from serious health problems. Yes, there is always a small risk that scientifically proven medicines carry, but those medicines also offer a huge benefit. Homeopathy carries a small or medium risk with no benefit,” he said.
Homeopaths say that illness-causing substances can, in minute doses, treat people who are unwell and dilute these substances in water or alcohol.
They say the resulting mixture retains a “memory” of the original substance that triggers a healing response in the body.
These claims have been disproven by multiple studies.
In 2015 the Australian National Health and Medical Research Council reviewed 225 research papers on homeopathy and found there were “no health conditions for which there is reliable evidence that homeopathy is effective.”
“People who choose homeopathy may put their health at risk if they reject or delay treatments for which there is good evidence for safety and effectiveness,” it said.
An independent company reviewed the council’s analysis and appraised the evidence to prevent bias, drawing the same conclusions.
Carr said the interim report on pharmacy regulation was not tough enough on the wider complementary and alternative medicine sector.
In September last year the Australian government announced a more comprehensive system of post-market monitoring of products, which would provide the Therapeutic Goods Administration with better information about emerging safety issues.
Because of these and other changes under way, the panel had made no further recommendations on complementary and alternative medicine products (CAM), King said.
However, Carr said he would liked to have seen a more critical look at the sale of such products in pharmacies by the panel.
“I’m particularly concerned by pharmacies that place naturopaths in the pharmacy environment, given naturopaths promote treatments that are unscientific and unproven,” he said.
Professor of public health and medicines policy expert Ken Harvey agreed.
“There should be a completely separate section for CAM products and there should be a clear sign in that section that tells customers: ‘These products have not been evaluated by government to see if they work and they may interact with medications. Talk to a pharmacist,’” he said.
The report also found that community pharmacy expenditure and funding was “insufficiently transparent,” a concern given that community pharmacies draw funding from a range of federal, state and territory government programs.
Pharmaceutical Society of Australia (PSA) president Joe Demarte said the interim report had raised some concerning issues for the sector.
“We will consult with members from all areas of practice to comprehensively assess the interim report, which will inform PSA’s detailed response,” he said.
LANDMARK CASE: ‘Every night we were dragged to US soldiers and sexually abused. Every week we were forced to undergo venereal disease tests,’ a victim said More than 100 South Korean women who were forced to work as prostitutes for US soldiers stationed in the country have filed a landmark lawsuit accusing Washington of abuse, their lawyers said yesterday. Historians and activists say tens of thousands of South Korean women worked for state-sanctioned brothels from the 1950s to 1980s, serving US troops stationed in country to protect the South from North Korea. In 2022, South Korea’s top court ruled that the government had illegally “established, managed and operated” such brothels for the US military, ordering it to pay about 120 plaintiffs compensation. Last week, 117 victims
China on Monday announced its first ever sanctions against an individual Japanese lawmaker, targeting China-born Hei Seki for “spreading fallacies” on issues such as Taiwan, Hong Kong and disputed islands, prompting a protest from Tokyo. Beijing has an ongoing spat with Tokyo over islands in the East China Sea claimed by both countries, and considers foreign criticism on sensitive political topics to be acts of interference. Seki, a naturalised Japanese citizen, “spread false information, colluded with Japanese anti-China forces, and wantonly attacked and smeared China”, foreign ministry spokesman Lin Jian told reporters on Monday. “For his own selfish interests, (Seki)
Argentine President Javier Milei on Sunday vowed to “accelerate” his libertarian reforms after a crushing defeat in Buenos Aires provincial elections. The 54-year-old economist has slashed public spending, dismissed tens of thousands of public employees and led a major deregulation drive since taking office in December 2023. He acknowledged his party’s “clear defeat” by the center-left Peronist movement in the elections to the legislature of Buenos Aires province, the country’s economic powerhouse. A deflated-sounding Milei admitted to unspecified “mistakes” which he vowed to “correct,” but said he would not be swayed “one millimeter” from his reform agenda. “We will deepen and accelerate it,” he
‘HYANGDO’: A South Korean lawmaker said there was no credible evidence to support rumors that Kim Jong-un has a son with a disability or who is studying abroad South Korea’s spy agency yesterday said that North Korean leader Kim Jong-un’s daughter, Kim Ju-ae, who last week accompanied him on a high-profile visit to Beijing, is understood to be his recognized successor. The teenager drew global attention when she made her first official overseas trip with her father, as he met with Chinese President Xi Jinping (習近平) and Russian President Vladimir Putin. Analysts have long seen her as Kim’s likely successor, although some have suggested she has an older brother who is being secretly groomed as the next leader. The South Korean National Intelligence Service (NIS) “assesses that she [Kim Ju-ae]
RSS